Patents by Inventor Seiji Tani
Seiji Tani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11890372Abstract: The present invention provides an infusion preparation that is inhibited from generation of unwanted insoluble matter after mixing of two liquids of the infusion preparation in long-term storage. More specifically, the present invention provides an infusion preparation comprising two chambers separated by a communicably openable partition, a first chamber containing a first-chamber infusion comprising a fat emulsion and further comprising at least one member selected from the group consisting of amino acids that have a buffer action, divalent organic acids, and trivalent organic acids, a second chamber containing a second-chamber infusion comprising an amino acid and at least calcium as an electrolyte, wherein a total concentration of the amino acids that have a buffer action, divalent organic acids, and trivalent organic acids in the first-chamber infusion is 0.15 to 0.5 g/L, and a mixture of the first- and second-chamber infusions has a pH of 6.Type: GrantFiled: March 13, 2019Date of Patent: February 6, 2024Assignee: OTSUKA PHARMACEUTICAL FACTORY, INC.Inventors: Seiji Tani, Seiji Fujita, Teru Nakai, Yasuhiro Kiuchi, Miyuki Yamanaka, Yui Hayashi, Hiroshi Kanno, Yu Saruwatari
-
Publication number: 20210007975Abstract: The present invention provides an infusion preparation that is inhibited from generation of unwanted insoluble matter after mixing of two liquids of the infusion preparation in long-term storage. More specifically, the present invention provides an infusion preparation comprising two chambers separated by a communicably openable partition, a first chamber containing a first-chamber infusion comprising a fat emulsion and further comprising at least one member selected from the group consisting of amino acids that have a buffer action, divalent organic acids, and trivalent organic acids, a second chamber containing a second-chamber infusion comprising an amino acid and at least calcium as an electrolyte, wherein a total concentration of the amino acids that have a buffer action, divalent organic acids, and trivalent organic acids in the first-chamber infusion is 0.15 to 0.5 g/L, and a mixture of the first- and second-chamber infusions has a pH of 6.Type: ApplicationFiled: March 13, 2018Publication date: January 14, 2021Applicant: OTSUKA PHARMACEUTICAL FACTORY, INC.Inventors: Seiji TANI, Seiji FUJITA, Teru NAKAI, Yasuhiro KIUCHI, Miyuki YAMANAKA, Yui HAYASHI, Hiroshi KANNO, Yu SARUWATARI
-
Patent number: 10393064Abstract: A seal structure for an internal combustion engine comprising: a cover side seal member which extends on upper surface sides or lower surface sides of both of an engine main body section and a chain casing and pressed and held against a cover member; a casing side seal member arranged at left or right end section of one end surfaces of the engine main body section onto which the chain casing is attached and pressed and held against the chain casing; a receiving concavity formed to extend on a junction surface of the chain casing to the cover member; and an extremely thick connection block section formed integrally on one end section of the casing side seal member, fitted into and retained by the receiving concavity, and projected more toward the cover member side than a junction surface of the chain casing to the cover member in a free state.Type: GrantFiled: April 4, 2017Date of Patent: August 27, 2019Assignee: MAHLE FILTER SYSTEMS JAPAN CORPORATIONInventors: Daizo Ito, Atsushi Nonaka, Seiji Tani
-
Patent number: 9884149Abstract: An object of the present invention is to provide an infusion preparation in which the Maillard reaction between an amino acid and a reducing sugar does not occur during storage and the size of fat particles in the fat emulsion does not increase during storage, and in which various types of vitamins can be incorporated in a stable manner, in spite of the fact that it is a two-chamber infusion preparation. Furthermore, even if only one of the infusions (of the infusion preparation) is administered, the patient is unlikely to develop hyperkalemia, vascular pain, or phlebitis. The present invention provides an infusion preparation containing two chambers separated by a partition that can be communicably opened, wherein a first chamber contains a first-chamber infusion containing a sugar and a fat emulsion, a second chamber contains a second-chamber infusion containing an amino acid and an electrolyte, the first-chamber infusion is substantially free of potassium, and has a relative osmotic pressure of 2.0 to 3.Type: GrantFiled: June 20, 2017Date of Patent: February 6, 2018Assignee: OTSUKA PHARMACEUTICAL FACTORY, INC.Inventors: Seiji Tani, Yasuhiro Mitsumoto
-
Publication number: 20170304530Abstract: An object of the present invention is to provide an infusion preparation in which the Maillard reaction between an amino acid and a reducing sugar does not occur during storage and the size of fat particles in the fat emulsion does not increase during storage, and in which various types of vitamins can be incorporated in a stable manner, in spite of the fact that it is a two-chamber infusion preparation. Furthermore, even if only one of the infusions (of the infusion preparation) is administered, the patient is unlikely to develop hyperkalemia, vascular pain, or phlebitis. The present invention provides an infusion preparation containing two chambers separated by a partition that can be communicably opened, wherein a first chamber contains a first-chamber infusion containing a sugar and a fat emulsion, a second chamber contains a second-chamber infusion containing an amino acid and an electrolyte, the first-chamber infusion is substantially free of potassium, and has a relative osmotic pressure of 2.0 to 3.Type: ApplicationFiled: June 20, 2017Publication date: October 26, 2017Applicant: OTSUKA PHARMACEUTICAL FACTORY, INC.Inventors: Seiji TANI, Yasuhiro MITSUMOTO
-
Publication number: 20170298864Abstract: A seal structure for an internal combustion engine comprising: a cover side seal member which extends on upper surface sides or lower surface sides of both of an engine main body section and a chain casing and pressed and held against a cover member; a casing side seal member arranged at left or right end section of one end surfaces of the engine main body section onto which the chain casing is attached and pressed and held against the chain casing; a receiving concavity formed to extend on a junction surface of the chain casing to the cover member; and an extremely thick connection block section formed integrally on one end section of the casing side seal member, fitted into and retained by the receiving concavity, and projected more toward the cover member side than a junction surface of the chain casing to the cover member in a free state.Type: ApplicationFiled: April 4, 2017Publication date: October 19, 2017Applicant: MAHLE FILTER SYSTEMS JAPAN CORPORATIONInventors: Daizo ITO, Atsushi NONAKA, Seiji TANI
-
Patent number: 9687600Abstract: An object of the present invention is to provide an infusion preparation in which the Maillard reaction between an amino acid and a reducing sugar does not occur during storage and the size of fat particles in the fat emulsion does not increase during storage, and in which various types of vitamins can be incorporated in a stable manner, in spite of the fact that it is a two-chamber infusion preparation. Furthermore, even if only one of the infusions (of the infusion preparation) is administered, the patient is unlikely to develop hyperkalemia, vascular pain, or phlebitis. The present invention provides an infusion preparation containing two chambers separated by a partition that can be communicably opened, wherein a first chamber contains a first-chamber infusion containing a sugar and a fat emulsion, a second chamber contains a second-chamber infusion containing an amino acid and an electrolyte, the first-chamber infusion is substantially free of potassium, and has a relative osmotic pressure of 2.0 to 3.Type: GrantFiled: December 18, 2015Date of Patent: June 27, 2017Assignee: OTSUKA PHARMACEUTICAL FACTORY, INC.Inventors: Seiji Tani, Yasuhiro Mitsumoto
-
Patent number: 9446184Abstract: An object of the present invention is to provide an infusion preparation in which the Maillard reaction between an amino acid and a reducing sugar does not occur during storage and the size of fat particles in the fat emulsion does not increase during storage, and in which various types of vitamins can be incorporated in a stable manner, in spite of the fact that it is a two-chamber infusion preparation. Furthermore, even if only one of the infusions (of the infusion preparation) is administered, the patient is unlikely to develop hyperkalemia, vascular pain, or phlebitis. The present invention provides an infusion preparation containing two chambers separated by a partition that can be communicably opened, wherein a first chamber contains a first-chamber infusion containing a sugar and a fat emulsion, a second chamber contains a second-chamber infusion containing an amino acid and an electrolyte, the first-chamber infusion is substantially free of potassium, and has a relative osmotic pressure of 2.0 to 3.Type: GrantFiled: November 28, 2011Date of Patent: September 20, 2016Assignee: OTSUKA PHARMACEUTICAL FACTORY, INC.Inventors: Seiji Tani, Yasuhiro Mitsumoto
-
Publication number: 20160101231Abstract: An object of the present invention is to provide an infusion preparation in which the Maillard reaction between an amino acid and a reducing sugar does not occur during storage and the size of fat particles in the fat emulsion does not increase during storage, and in which various types of vitamins can be incorporated in a stable manner, in spite of the fact that it is a two-chamber infusion preparation. Furthermore, even if only one of the infusions (of the infusion preparation) is administered, the patient is unlikely to develop hyperkalemia, vascular pain, or phlebitis. The present invention provides an infusion preparation containing two chambers separated by a partition that can be communicably opened, wherein a first chamber contains a first-chamber infusion containing a sugar and a fat emulsion, a second chamber contains a second-chamber infusion containing an amino acid and an electrolyte, the first-chamber infusion is substantially free of potassium, and has a relative osmotic pressure of 2.0 to 3.Type: ApplicationFiled: December 18, 2015Publication date: April 14, 2016Applicant: OTSUKA PHARMACEUTICAL FACTORY, INC.Inventors: Seiji TANI, Yasuhiro MITSUMOTO
-
Patent number: 9027936Abstract: A gasket is provided which is intended to improve its sealing performance by attaining a further stabilization of the posture thereof in a groove.Type: GrantFiled: July 23, 2009Date of Patent: May 12, 2015Assignees: Nok Corporation, Mahle Filter Systems Japan CorporationInventors: Shuji Yoshitsune, Masaru Ito, Tomoyuki Koyama, Seiji Tani
-
Publication number: 20130313261Abstract: An object of the present invention is to provide an infusion preparation in which the Maillard reaction between an amino acid and a reducing sugar does not occur during storage and the size of fat particles in the fat emulsion does not increase during storage, and in which various types of vitamins can be incorporated in a stable manner, in spite of the fact that it is a two-chamber infusion preparation. Furthermore, even if only one of the infusions (of the infusion preparation) is administered, the patient is unlikely to develop hyperkalemia, vascular pain, or phlebitis. The present invention provides an infusion preparation containing two chambers separated by a partition that can be communicably opened, wherein a first chamber contains a first-chamber infusion containing a sugar and a fat emulsion, a second chamber contains a second-chamber infusion containing an amino acid and an electrolyte, the first-chamber infusion is substantially free of potassium, and has a relative osmotic pressure of 2.0 to 3.Type: ApplicationFiled: November 28, 2011Publication date: November 28, 2013Applicant: OTSUKA PHARMACEUTICAL FACTORY, INC.Inventors: Seiji Tani, Yasuhiro Mitsumoto
-
Patent number: 8404274Abstract: There is provided an aseptic combination preparation to be mixed at the time of use, characterized in that the same medicinal ingredients are divided and preserved in two or more chambers. The aseptic combination preparations according to the present invention are a mixing type at the time of their use and are useful as infusions, various dialysis fluids, intraocular perfusion/washing solutions, coronary perfusion solutions, myocardial protective solutions, peritoneal lavage solutions, solutions for organ preservations, etc., which can eliminate adverse effects caused by medical error on a living body.Type: GrantFiled: June 4, 2004Date of Patent: March 26, 2013Assignee: Otsuka Pharmaceutical Factory, Inc.Inventors: Nobuaki Sumiyoshi, Yasuhiro Mitsumoto, Shigeaki Arita, Seiji Tani, Masaru Kobayashi
-
Patent number: 8136819Abstract: There is provided a sealing structure and a gasket which can seal both of a portion where a groove for mounting the gasket is formed and a portion where a groove for mounting the gasket is not formed when the portions are connected. The gasket includes a first gasket portion 110 which has a first mounted portion 111 to be mounted in a first groove 211 to come in close contact with a bottom face 211a of the first groove 211 and which is formed in a shape along an end portion of an outer wall portion 210 and a second gasket portion 120 which has a second mounted portion 150 to be mounted in a second groove 221 near a portion connected to the first gasket portion 110 and which is formed in a shape along an end portion 220 of a partition wall 220, the second mounted portion 150 having an inclined face for coming in close contact with the inclined bottom face 221a of the second groove 221.Type: GrantFiled: March 12, 2008Date of Patent: March 20, 2012Assignees: Nok Corporation, MAHLE Filter Systems Japan CorporationInventors: Shuji Yoshitsune, Kiyohiro Suzuki, Manshu Kameike, Seiji Tani, Hideki Tanaka, Shin Yoshida, Masanori Sudo
-
Publication number: 20110193298Abstract: A gasket is provided which is intended to improve its sealing performance by attaining a further stabilization of the posture thereof in a groove.Type: ApplicationFiled: July 23, 2009Publication date: August 11, 2011Applicants: NOK CORPORATION, MAHLE Filter Systems Japan CorporationInventors: Shuji YOSHITSUNE, Masaru Ito, Tomoyuki Koyama, Seiji Tani
-
Publication number: 20100329242Abstract: According to one embodiment, a server apparatus includes a memory, a determination module and a controller. The memory stores a management table associating terminal IDs specifying the terminals with media processing abilities owned by the terminals. The determination module refers the management table and determines whether information showing a media processing ability corresponding to the first terminal and information showing a media processing ability corresponding to the second terminal coincide with each other based on the reference result. The controller executes first processing for making speech connection between the first terminal and the second terminal by a peer-to-peer when the media processing abilities coincide with each other, and executes second processing for leading in a speech path between the first terminal and the second terminal to convert into the same media processing ability when the media processing abilities non-coincide with each other.Type: ApplicationFiled: June 16, 2010Publication date: December 30, 2010Inventors: Atsushi Yamazaki, Seiji Tani
-
Patent number: 7815198Abstract: A gasket is to be disposed in a compressed state between a groove bottom surface defining a gasket groove formed in a first member and a seat surface of a second member so as to make a hermetical sealing between the groove bottom surface and the seal surface. The gasket includes a first seal section formed at an end part of the gasket in a compression direction. The first seal section is ridge-shaped so as to become slender in a direction toward a tip portion of the first seal section. The first seal section has first and second side surfaces which are opposite to each other with respect to a first plane passing through the tip portion of the first seal section. The first side surface overhangs outwardly larger than the second side surface.Type: GrantFiled: June 22, 2006Date of Patent: October 19, 2010Assignee: Mahle Filter Systems Japan CorporationInventor: Seiji Tani
-
Publication number: 20100102519Abstract: There is provided a sealing structure and a gasket which can seal both of a portion where a groove for mounting the gasket is formed and a portion where a groove for mounting the gasket is not formed when the portions are connected. The gasket includes a first gasket portion 110 which has a first mounted portion 111 to be mounted in a first groove 211 to come in close contact with a bottom face 211a of the first groove 211 and which is formed in a shape along an end portion of an outer wall portion 210 and a second gasket portion 120 which has a second mounted portion 150 to be mounted in a second groove 221 near a portion connected to the first gasket portion 110 and which is formed in a shape along an end portion 220 of a partition wall 220, the second mounted portion 150 having an inclined face for coming in close contact with the inclined bottom face 221a of the second groove 221.Type: ApplicationFiled: March 12, 2008Publication date: April 29, 2010Applicants: NOK CORPORATION, MAHLE FILTER SYSTEMS JAPAN CORPORATIONInventors: Shuji Yoshitsune, Kiyohiro Suzuki, Manshu Kameike, Seiji Tani, Hideki Tanaka, Shin Yoshida, Masanori Sudo
-
Publication number: 20080019488Abstract: According to one embodiment, a communication system includes a plurality of voice mail apparatuses which include mailboxes corresponding to a plurality of telephone terminals, and record a voice message transmitted to any one of the plural telephone terminals in a mailbox corresponding to the telephone terminal and a file server which is connected to each of the plural voice mail apparatuses via a network and includes a plurality of common mailboxes to be used in common with the plural voice mail apparatuses, wherein each of the plurality of voice mail apparatuses include a controller which transfers the voice message to the file server via the network in order to record the voice message in any one of the common mailboxes, when there is a request to record the voice message.Type: ApplicationFiled: July 20, 2007Publication date: January 24, 2008Applicant: KABUSHIKI KAISHA TOSHIBAInventors: Seiji Tani, Shuichi Sato
-
Publication number: 20060290075Abstract: A gasket is to be disposed in a compressed state between a groove bottom surface defining a gasket groove formed in a first member and a seat surface of a second member so as to make a hermetical sealing between the groove bottom surface and the seal surface. The gasket includes a first seal section formed at an end part of the gasket in a compression direction. The first seal section is ridge-shaped so as to become slender in a direction toward a tip portion of the first seal section. The first seal section has first and second side surfaces which are opposite to each other with respect to a first plane passing through the tip portion of the first seal section. The first side surface overhangs outwardly larger than the second side surface.Type: ApplicationFiled: June 22, 2006Publication date: December 28, 2006Inventor: Seiji Tani
-
Publication number: 20060211631Abstract: The infusion preparation for peripheral parenteral administration comprises an infusion (A) containing glucose with 80 to 200 g/L concentration, and an infusion (B) containing amino acid with 50 to 150 g/L concentration. The infusion (A) and the infusion (B) are separately put into a vessel that is divided with an openable partition means. The infusion (A) does not contain sulfite, has titratable acidity of 1 or less, contains vitamin B1 and is adjusted to pH 3 to 5. The infusion (B) is adjusted to pH 6.5 to 8. After mixing the both infusions, the mixture has pH 6 to 7.5 and titratable acidity of 5 to 10.Type: ApplicationFiled: May 14, 2004Publication date: September 21, 2006Inventors: Yasuhiro Mitsumoto, Shigeaki Arita, Seiji Tani, Nobuaki Sumiyoshi